John G Ullman & Associates Inc Haleon PLC Transaction History

John G Ullman & Associates Inc

  • $649 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023
SELL
$7.57 - $8.37 $64,723 - $71,563
-8,550 Reduced 3.6%
229,062 $1.87 Million
Q4 2022

Feb 08, 2023
SELL
$5.96 - $8.06 $422,444 - $571,292
-70,880 Reduced 22.98%
237,612 $1.9 Million
Q3 2022

Oct 19, 2022
BUY
$5.63 - $7.5 $1.74 Million - $2.31 Million
308,492 New
308,492 $1.88 Million

Others Institutions Holding HLN

# of Institutions
639
Shares Held
412M
Call Options Held
149K
Put Options Held
16K
View Full List

About Haleon plc

HLN Quotes by TradingView
  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email